Open Access

Very low sensitivity of wet mount microscopy compared to PCR against culture in the diagnosis of vaginal trichomoniasis in Uganda: a cross sectional study

BMC Research Notes201710:259

https://doi.org/10.1186/s13104-017-2581-1

Received: 7 September 2016

Accepted: 28 June 2017

Published: 6 July 2017

Abstract

Background

Trichomonas vaginalis (TV) causes the Trichomoniasis Syndrome composed of vaginitis in women, urethritis in men and tube infection in both sexes. This infection is strongly associated with premature rupture of membranes, preterm delivery, low birth weight, promoting HIV sexual transmission and infertility. Prevention of these complications requires accurate early detection and effective treatment of infected individuals. In the resource limited settings, the wet mount microscopy (WMM) is often the only available test for laboratory detection of TV, but its accuracy and that of polymerase chain reaction (PCR) tools in Uganda remain poorly studied. The aim of this cross-sectional study was to compare the diagnostic accuracy of the WMM and PCR against culture as reference standard for the direct diagnosis of TV among symptomatic women. Three high vaginal swabs were collected from each of one hundred fifty women presenting with symptoms suggestive of active vaginal trichomoniasis at the sexually transmitted diseases clinic of Mulago National Referral Hospital Kampala, Uganda. The swabs were tested for TV with WMM, in-house PCR and TV culture. Results were analysed using excel 2007, SPSS v16, and Meta-disc software to determine the diagnostic accuracy of the tests.

Results

The sensitivity, specificity and kappa agreement of the WMM was 25% (95% CI 5.5–57.2%), 100% (95% CI 97–100) and 0.38, respectively. Corresponding values for the PCR were 91.7% (95% CI 61.5–99.8), 99.3% (95% CI 96–100) and 0.91, respectively.

Conclusion

Among the TV symptomatic women, the sensitivity of the WMM was very low, with two-thirds of the patients missing a diagnosis while the in-house PCR was highly sensitive and specific. Feasibility studies aimed at incorporating PCR tools in algorithms for diagnosis of TV infection in resource-limited settings are recommended.

Keywords

Trichomonas vaginalis Sexually transmitted infections Trichomoniasis Wet mount microscopy Polymerase chain reaction

Background

Trichomonas vaginalis (TV) is an extracellular, facultative anaerobic infection of the human urogenital tract. Infection is associated with premature rupture of membranes, preterm delivery, low birth weight, HIV sexual transmission [1], and pelvic inflammatory disease [24]. The WHO estimates that at least 174 million cases of infection are acquired annually worldwide, majority in regions of low income settings [5, 6]. The prevalence of TV infection differs in different subpopulation groups, e.g. in women, it is estimated to be ten times higher than in males [7, 8]. In the USA, 13% of black women are affected compared with 1.8% of non-Hispanic white women [9], but a higher prevalence has been reported among STD clinic patients i.e. 26% of symptomatic women and 6.5% asymptomatic women tested [9]. In Tanzania and Uganda, a TV prevalence of 41% in Mwanza and 31% in Rakai district, respectively was reported [10]. Most infected persons (70–85%), both men and females have minimal or no symptoms, and untreated infections might last for months to years [11]. Early accurate detection of TV infection in both symptomatic and asymptomatic women plus effective treatment is critical in the prevention of associated complications especially during pregnancy [11].

The diagnosis of TV infection in the current study setting relies on clinical symptoms with or without wet mount microscopy (WMM). Clinical symptoms tend to be non-specific as they cut across a number of other STDs, and are therefore poor indicators of TV infection. The WMM is a rapid and inexpensive test as it involves examination of vaginal fluid in saline under low power microscopy. However, it is associated with limited sensitivity of 38–65% as it depends highly on the expertise of the Microscopist, and prompt processing of samples before the organisms lyse or lose motility, and its sensitivity is even lower among the asymptomatic patients [1113]. Culture for TV, with sensitivity of 75–96% and a specificity of up to 100%, used to be considered the reference standard for TV diagnosis before molecular tests became available [14]. However, due to its high cost and lengthy time to results of up to 7 days, culture is rarely used in routine setting of resource-poor settings in the diagnosis of TV infection [15].

Recent advancement has led to the development of highly sensitive and specific polymerase chain reaction (PCR)/nucleic acid amplification techniques/tests (NAATs) that offer faster means to detection of TV infection in endocervical, vaginal, or urine specimens from women. These include The APTIMA T. vaginalis assay (Hologic Gen-Probe, San Diego, CA), which detects RNA by transcription-mediated amplification with a sensitivity of 95.3–100% and specificity of 95.2–100% [16], the BD Probe Tec TV Qx Amplified DNA Assay (Becton–Dickinson, Franklin Lakes, New Jersey), and the Affirm VP III (Becton–Dickinson, Sparks, MD), a DNA hybridization probe test that evaluates for T. vaginalis, G. vaginalis, and Candida albicans, in only 45 min with sensitivity and specificity of 63 and 99.9%, respectively [17]. Studies on the performance of these PCR assays have mainly been conducted in the developed countries such as USA, Europe, and Australia, and show PCR sensitivity to be 89–98% [18, 19]. These NAATs have become routine assays in developed countries however, in the resource-limited settings the high cost of these commercially available NAATs remains a prohibitive challenge to their use. The objective of this study was to evaluate the technical performance of a cheaper in-house PCR technique in comparison with the conventional WMM against culture as reference standard test for the diagnosis of TV infection in Uganda.

Methods

This was a cross-sectional prospective and consecutive diagnostic accuracy study conducted from March 2014 to March 2015, at the STD clinic Mulago national referral hospital. Laboratory tests including WMM, PCR and culture were performed at the STD clinic, MBN Clinical Laboratories and Infectious Diseases Institute respectively, all in Kampala, Uganda.

Participant recruitment

A total of 150 female participants aged 18–60 years attending the STD clinic with symptoms suggestive of TV infection e.g. malodour, abnormal discharge, painful sexual intercourse, dysuria, genital itching and lower abdominal pain voluntarily consented to participate in the study. Exclusion criteria included refusal to consent, being in menstrual period, and history of taking nitro-imidazoles within the past 2 weeks Additional file 1.

Sample collection

Three vaginal swabs were collected from the posterior fornix by an experienced clinician under a Cusco’s speculum guidance.

Wet mount microscopy

One vaginal swab was emulsified in three drops of 0.9% saline on a glass slide and examined for motile trichomonads under 100× and 400× microscopy within 30 min of collection as routinely done at the clinic. Microscopic examination was done by one experienced laboratory technician at the STD clinic and by the researcher. Presence of motile trichomonads indicated a positive result for TV infection. No discrepant results were obtained between the two viewers.

Culture

The second vaginal swab was used within around 20 min to inoculate the InPouch™ TV culture chambers (BioMed Diagnostics, USA) at the STD clinic laboratory following the manufacturer’s instructions. Inoculated chambers were incubated in an upright position at 37 °C for up to 7 days. Microscopic examinations were performed on days 1, 2, 3 5 and 7 to check for the presence of motile trichomonads in the upper chamber (Additional file 2).

In-house PCR for TV

PCR swabs were temporarily stored up to 3 weeks at minus 20 °C to prepare for batched DNA extraction and PCR assays.

DNA extraction

Extraction of TV DNA (if present) was performed using the phenol chloroform method. Briefly, each swab was dipped in sterile 10% sodium dodecyl sulphate (SDS) solution contained in a 1.5 ml eppendorf tube, and heated for 5 min at 65 °C. The swabs were then squeezed against the wall of the tube to express fluids. A volume of 100 µl of sodium acetate was added to neutralize the alkaline component of the lysis solution. A volume of 600 µl of phenol chloroform and 25 µl PCR water was then added. The mixture was vortexed and span at maximum speed (14000 rpm) for 30 min. Purification of extracted DNA was achieved by precipitation using absolute isopropanol. Final DNA precipitate was dissolved in 50 µl of PCR water and stored at −20 °C until amplification.

DNA Amplification

Each PCR reaction tube contained 1.0 µl of 25 mmol Magnesium chloride, 1.0 µl, Forward primer 1.0 µl, Reverse primer, 0.1 µl Taq polymerase, master mix with dNTPs 1.0 µl and PCR water 7.0 µl, giving a final volume of 11.1 µl. The forward primer AP65 A_5′GATTCCTCTTCACACACCCACCAG3′ and Reverse primer AP65 B_5′AATACGGCCAGCATCTGTAACGAC3′ were designed to target a conserved region in the AP65 adhesin genes of T. vaginalis, giving a 209 base pair (bp) amplification product [20]. Template DNA 2 µl was added to the mixture and loaded onto a Gene Amp PCR System 9700 Thermocycler (Applied Biosystems Inc.). The amplification program included one cycle of initial denaturation at 95 °C for 5 min, followed by 30 cycles of: denaturation at 94 °C for 45 s, annealing at 53 °C for 45 s, extension at 72 °C for 45 s, followed by one cycle of final extension at 72 for 10 min and storage at 4.0 °C.

Detection of amplification products

This was performed with 1.5% agarose gel electrophoresis at 120 volts for 45 min. Gel images were viewed under ultraviolet light trans-illuminator and a gel picture taken with a digital UV camera. Presence of 209 bp band on the gel as indicated a positive result for TV (Fig. 1).
Fig. 1

Gel electrophoresis image of post PCR products of the Trichomonas vaginalis Adhesin gene. Lanes 1 and 12: 1000 bp Ladder, Lane 2: Positive control (PC) showing a 209 bp band size, Lane 3, 6, 7, 9, and 13: Samples positive for TV, Lane 4, 5, 8, 10, 11, and 12: Samples Negative for TV, Lane 15: Negative control (NC)

Quality control

Each batch of PCR included controls at all stages. Positive controls included DNA extracted from a clinical isolate of Trichomonas vaginalis grown in vitro, while negative controls consisted of nuclease-free water in the place of template DNA. A 1000 kb ladder (Solis BioDye) was used as a size marker.

Results

The table showing all the analysed study data is provided as Additional file 3.

Demographic and clinical characteristics of study participants

The demographics and other clinical details of the studied participants are summarised in Table 1.
Table 1

Demographic and clinical characteristics of study participants (N = 150)

Parameter

Categories

Frequency

Percentage

Marital status

Single

81

54.0

Married

52

34.6

Separated

9

5.0

Widowed

4

2.7

Unknown

4

2.7

Education status

High school

68

55.4

Unknown

37

24.7

Tertiarya

22

14.7

Primary level

21

14.0

None

2

1.3

Abnormal discharge

Yes

125

83.3

No

25

16.7

Dysuria

Yes

31

20.7

No

119

79.3

Genital itching

Yes

72

48.0

No

78

52.0

Lower abdominal pain

Yes

63

42.0

No

87

58.0

Malodour

Yes

41

27.3

No

109

72.7

Antibiotic use

Yes

52

34.7

No

98

65.3

aCertificate, diploma and degree awarding institutions

Prevalence of TV infection

Out of 150 participants, 13 were diagnosed with TV infection using either one, two or all the three tests giving a prevalence of 9% as detailed in Table 2.
Table 2

Prevalence of TV infection by each test (n = 150)

Method

Prevalence (%)

(95% CI)

Combined wet mount microscopy, InPouch™ TV culture and in-house PCR

13 (9)

5–14%

Wet mount microscopy (WMM)

3 (2)

1–6%

InPouch™ TV culture

12 (8)

5–13%

In-house PCR

12 (8)

5–13%

It was found that 69% of all the confirmed infection (by culture) cases had an abnormal vaginal discharge, 54% with dysuria, 46% with genital itching, 31% with malodor, and 31% with lower abdominal pain.

Sensitivity and specificity of WMM and PCR against culture

Using culture as reference standard, the sensitivity, specificity and kappa agreement of wet mount microscopy was 25% (95% CI 5.5–57.2), 100% (95% CI, 97.4–100.0), and 0.38 respectively. Corresponding values for the in-house PCR were 91.7% (95% CI, 61.5–99.8), specificity 99.3% (95% CI, 96–100.0) and 0.91 in the detection of TV in high vaginal swabs among symptomatic women in Uganda. See Table 3 for details.
Table 3

Accuracy of wet mount microscopy and in-house PCR against Culture for TV diagnosis

Culture

Test

TP

FP

FN

TN

Sensitivity (95% CI)

Specificity (95% CI)

Kappa agreement

PPV (95% CI)

NPV (95% CI)

PCR

11

1

1

137

91.7 (61.5–99.8)

99.3 (96.0–100.0)

0.91

91.6% (60.8–98.7%)

99.3% (95.5–99.9%)

Wet mount

3

0

9

138

25.0 (5.5–57.2)

100 (97.4–100.0)

0.38

100% (CI NA)

93.8% (91.7–95.5%)

95% CI 95% Confidence interval, FN False negative, FP False positive, NA Not applicable, NPV Negative predictive value, PPV Positive predictive value, TN True negative, TP True positive

Discussion

The prevalence of TV infection in this study was 8.6% based on all positive tests. Various studies report different prevalence values ranging from 13 to 41% based on the methods used, study settings, social-demographics and symptomatology of studied populations [4, 9, 10]. In high-risk populations such as female sex workers in sub-Saharan Africa (SSA), the prevalence of active TV infection can be as high as 47% [21]. However, the relationship between symptoms and presence of active TV infection also varies since the symptoms are not very specific. In this study, less than 10% of symptomatic women were confirmed with TV infection. Thus, it appears that in the studied population, TV infection diagnosis requires diagnostic algorithms that include highly sensitive laboratory tests. The in-house PCR was highly sensitive and specific for the detection of TV DNA in vaginal swabs, and far out performed the routinely used WMM in the study setting. In our study, the phenol chloroform method was employed for DNA extraction. If costs would allow, it would be better to use extraction columns like silica-membrane-based DNA purification, believed to increase TV detection; consequently the prevalence of trichomoniasis could probably have been higher in our study. Methodological issues can also affect WMM. Studies elsewhere have shown that the low sensitivity of WMM can further be decreased by 20% with delayed microscopic examination for as few as 10 min [22]. In our study, even when the wet preparation was performed at the sample collection site, by the experienced reader who routinely performs the wet preparations at the clinic, its sensitivity (25%) was still poor. Various studies using related but not exactly the same study designs report the sensitivity of WMM to range from around 38 to 65% [4, 11, 18, 23]. Testardini et al. reported sensitivity of WMM of 45.8% in all the patients studied but it increased to 87.5% in symptomatic patients but in their study, one millilitre of physiologic saline was used instead three drops [4]. Use of three drops instead of 1 ml of physiologic saline solution could be a limitation leading to the lower sensitivity of WMM obtained in our study. These results all together indicate the superiority of PCR over WMM.

Two discrepant results emerged between PCR and culture, one of which was culture positive and PCR negative, and the other culture negative and PCR positive. For the PCR negative sample, we suspect that the PCR swab may have been poorly collected, such that extracted DNA was below the limit of PCR detection. Non-specific PCR inhibitors in the sample could also have inhibited amplification. A strategy to find out this would be inclusion of controls for the presence of amplifiable DNA and PCR inhibitors in each clinical sample using PCR for a human gene. If any sample remains negative for this gene, it would not be included in the data analysis. Consequently, the prevalence of trichomoniasis could have been slightly different, and this could be a limitation in our study. Too much DNA could also inhibit amplification requiring dilution of extracted DNA to optimize the PCR reaction. A dilution of the sample could correct the inhibitory effect, so the results could be positive and consequently, the prevalence of trichomoniasis could have been higher. However, when we diluted and repeated the PCR test, the results remained unchanged.

Regarding the PCR-positive culture negative result, this result may not really be a false positive because the PCR has recently been reported to be more sensitive than culture [24]. This result could also be due to inoculation of culture media with already dead organisms in the sample. Since PCR detects presence of DNA, it is not affected by the viability of the microorganisms in the sample. All positive WMM results were also positive with both the PCR and culture results. It appears that to improve the diagnosis of TV infection, combining methods with higher sensitivity such as culture and PCR are recommended, mainly in asymptomatic pregnant women.

Implications of our findings

Given the high risks of TV infection to pregnancy and increased HIV transmission/acquisition, prompt detection and treatment should be considered critical. Combined methods such as culture and PCR is recommended, since culture depends only on the viability of the microorganism and PCR is unaffected by dead organisms but by inhibitors.

Conclusion

Among the TV symptomatic women, the sensitivity of the WMM was very low, with two-thirds of the patients missing a diagnosis while the in-house PCR was highly sensitive and specific. Feasibility studies aimed at incorporating PCR tools in algorithms for diagnosis of TV infection among symptomatic women in resource-limited settings are recommended. For WMM, increasing the sample volume and volume of saline to one ml might help to increase the test sensitivity.

Abbreviations

ELISA: 

enzyme-linked immunosorbent assay

HIV: 

human immunodeficiency virus

NAATs: 

nucleic acid amplification tests

PCR: 

polymerase chain reaction

Rpm: 

revolutions per minute

STD: 

sexually transmitted disease

STI: 

sexually transmitted infection

TV: 

Trichomonas vaginalis

WHO: 

World Health Organisation

WMM: 

wet mount microscopy

µl: 

micro litre

Declarations

Authors’ Contributions

SN participated in study design, data collection, sample analysis, data analysis and preparing the first draft of the manuscript. OK participated in critical review of the study design, protocol and the manuscript. SS contributed in the critical review of the study design, protocol, and the manuscript. AO, and IN participated in sample processing and analysis in the laboratory and review of the manuscript, HO participated in sample processing, analysis and review of manuscript, JK participated in sample collection and review of the manuscript. FB participated in study design, sample analysis, data analysis and critical review of the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We are grateful to the staff of STD clinic for their support in sample collection, the MBN Clinical Laboratories staff, the Translational Research Laboratory staff, and the Microbiology Department of Makerere University. Your contribution towards the success of this project is greatly appreciated.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All data generated and analyzed during this study are included in this published article as Additional file 3.

Consent for publication

Patients consented to publication of the findings without their personal identifier information.

Ethics approval and consent to participate

This study was approved by the School of Biomedical Sciences Higher Degrees Research and Ethics Committee (SBS-HDREC) of Makerere University, College of Health Sciences; (Approval file No: SBS 164). All study participants voluntarily consented to participate in the study.

Funding

This study was funded by the researchers SN, FB and by MBN Clinical Laboratories.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Medical Microbiology, Makerere University College of Health Sciences
(2)
Department of Obstetrics/Gynaecology, Makerere University College of Health Sciences
(3)
Infectious Diseases Institute, Makerere University College of Health Sciences
(4)
MBN Clinical Laboratories
(5)
Sexually Transmitted Diseases Clinic Mulago Hospital Kampala

References

  1. Van der Pol B. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis. 2007;44(1):23–5.View ArticlePubMedGoogle Scholar
  2. Cherpes TL, Wiesenfeld HC, Melan MA, Kant JA, Cosentino LA, Meyn LA, et al. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis. 2006;33(12):747–52.View ArticlePubMedGoogle Scholar
  3. Cotch MF, Pastorek JG 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 1997;24(6):353–60.View ArticlePubMedGoogle Scholar
  4. Testardini P, Vaulet ML, Entrocassi AC, Menghi C, Eliseht MC, Gatta C, et al. Optimization of Trichomonas vaginalis Diagnosis during Pregnancy at a University Hospital, Argentina. Korean J Parasitol. 2016;54(2):191–5.View ArticlePubMedPubMed CentralGoogle Scholar
  5. World Health Organization: Global prevalence and incidence of selected curable sexually transmitted infections. Geneva: WHO Press. 2001.Google Scholar
  6. World Health Organization. The world health report making a difference. Geneva: Organisation Press; 1999. p. 2010.Google Scholar
  7. HobbsMM, Sena AC, Swygard H, Schwebke JR. Trichomonas vaginalis and trichomoniasis. In: Holmes K, Holmes KK, Sparling PF, Sparling P, Stamm WE, Stamm W, Piot P, Wasserheit, JN, Wasserheit J, Corey L, Cohen MS, Cohen M (Eds). Sexually transmitted diseases. 2008. p. 771–793.Google Scholar
  8. Poole DN, McClelland RS. Global epidemiology of Trichomonas vaginalis. Sex Transm Infect. 2013;89(6):418–22.View ArticlePubMedGoogle Scholar
  9. Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004. Clin Infect Dis. 2007;45(10):1319–26.View ArticlePubMedGoogle Scholar
  10. Orroth KK, Korenromp EL, White RG, Changalucha J, de Vlas SJ, Gray RH, et al. Comparison of STD prevalences in the Mwanza, Rakai, and Masaka trial populations: the role of selection bias and diagnostic errors. Sex Transm Infect. 2003;79(2):98–105.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1–137.PubMedGoogle Scholar
  12. Radonjic IV, Dzamic AM, Mitrovic SM, Arsic Arsenijevic VS, Popadic DM, Kranjcic Zec IF. Diagnosis of Trichomonas vaginalis infection: the sensitivities and specificities of microscopy, culture and PCR assay. Eur J Obstet Gynecol Reprod Biol. 2006;126(1):116–20.View ArticlePubMedGoogle Scholar
  13. Caliendo AM, Jordan JA, Green AM, Ingersoll J, Diclemente RJ, Wingood GM. Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect Dis Obstet Gynecol. 2005;13(3):145–50.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Nye MB, Schwebke JR, Body BA. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol. 2009;200(2):188-e1–7.View ArticleGoogle Scholar
  15. Fouts AC, Kraus SJ. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis. 1980;141(2):137–43.View ArticlePubMedGoogle Scholar
  16. Sosman JM, MacGowan RJ, Margolis AD, Eldridge E, Flanigan T, Vardaman J, et al. Screening for sexually transmitted diseases and hepatitis in 18–29 year-old men recently released from prison: feasibility and acceptability. Int J STD AIDS. 2005;16(2):117–22.View ArticlePubMedGoogle Scholar
  17. Andrea SB, Chapin KC. Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VP III for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications. J Clin Microbiol. 2011;49(3):866–9.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Simpson P, Higgins G, Qiao M, Waddell R, Kok T. Real-time PCRs for detection of Trichomonas vaginalis beta-tubulin and 18S rRNA genes in female genital specimens. J Med Microbiol. 2007;56(Pt 6):772–7.View ArticlePubMedGoogle Scholar
  19. Nathan B, Appiah J, Saunders P, Heron D, Nichols T, Brum R, et al. Microscopy outperformed in a comparison of five methods for detecting Trichomonas vaginalis in symptomatic women. Int J STD AIDS. 2015;26(4):251–6.View ArticlePubMedGoogle Scholar
  20. Alderete JF, O’Brien JL, Arroyo R, Engbring JA, Musatovova O, Lopez O, et al. Cloning and molecular characterization of two genes encoding adhesion proteins involved in Trichomonas vaginalis cytoadherence. Mol Microbiol. 1995;17(1):69–83.View ArticlePubMedGoogle Scholar
  21. Rassjo EB, Kambugu F, Tumwesigye MN, Tenywa T, Darj E. Prevalence of sexually transmitted infections among adolescents in Kampala, Uganda, and theoretical models for improving syndromic management. J Adolesc Health. 2006;38(3):213–21.View ArticlePubMedGoogle Scholar
  22. Kingston MA, Bansal D, Carlin EM. ‘Shelf life’ of Trichomonas vaginalis. Int J STD AIDS. 2003;14(1):28–9.View ArticlePubMedGoogle Scholar
  23. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis. Clin Infect Dis. 2002;35(5):576–80.View ArticlePubMedGoogle Scholar
  24. Domeika M, Zhurauskaya L, Savicheva A, Frigo N, Sokolovskiy E, Hallen A, et al. Guidelines for the laboratory diagnosis of trichomoniasis in East European countries. J Eur Acad Dermatol Venereol. 2010;24(10):1125–34.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2017

Advertisement